Previous Close | 2.3400 |
Open | 2.3700 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 2.3100 - 2.3700 |
52 Week Range | 2.3000 - 5.5600 |
Volume | |
Avg. Volume | 110,000 |
Market Cap | 102.922M |
Beta (5Y Monthly) | 1.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2500 |
Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.25 |
Despite a revenue dip, Harvard Bioscience Inc (HBIO) focuses on new product launches and cost-saving measures to drive future growth.
New products complement an already extensive range of products enabling fundamental advancements in neuroscience researchHOLLISTON, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) 2024 Annual Meeting being held October 5 - 9 in Chicago. Cutting-edge innovations on display include the revolutionary new Mesh MEA™ microelectrode array system, the SoHo™ imp